The Grail Galleri test is one of the first blood test that looks for fragments of DNA circulating in the bloodstream and scans for markers that might have come from a tumor cell. Cancer screening ...

A number of next-generation screenings developed in recent years and sold online could address both of these problems.

Researchers in the UK say Grail’s blood test for more than 50 different types of cancer has shown promise in a trial involving thousands of people with suspected cancer symptoms. A blood test ...

Grail is aiming to develop a readily available cancer test based on circulating tumour DNA – snippets of genetic material from cancer carried in the blood stream that could be used to diagnose ...

Grail Inc ( (GRAL) ) has released its Q3 earnings. Here is a breakdown of the information Grail Inc presented to its investors. Grail Inc. is a ...

Early detection is key to survival, but still, 70% of cancers didn’t have screening tests -- until now. What’s being considered the “holy grail” of cancer screening could diagnose some ...

Today, John Hancock, a unit of Toronto-based Manulife, announced it is providing free access to Galleri®, GRAIL's ...

Grail (GRAL) announced early results ... with other populations that have received the MCED test. Among the 37 participants with a Cancer Signal Detected, 12 cancer diagnoses were confirmed.

The multi-cancer early detection (MCED) test made by Grail is the first MCED test to be laboratory approved. The test is intended for people who are over 50. It is not recommended for people under ...

The multi-cancer early detection or MCED test made by Grail is the first MCED test to be laboratory-approved. The test is intended for people who are over 50. It is not recommended for people under ...